These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9707600)

  • 1. Differential thymic selection outcomes stimulated by focal structural alteration in peptide/major histocompatibility complex ligands.
    Ghendler Y; Teng MK; Liu JH; Witte T; Liu J; Kim KS; Kern P; Chang HC; Wang JH; Reinherz EL
    Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10061-6. PubMed ID: 9707600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymic selection is influenced by subtle structural variation involving the p4 residue of an MHC class I-bound peptide.
    Sasada T; Ghendler Y; Wang JH; Reinherz EL
    Eur J Immunol; 2000 May; 30(5):1281-9. PubMed ID: 10820373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A naturally processed mitochondrial self-peptide in complex with thymic MHC molecules functions as a selecting ligand for a viral-specific T cell receptor.
    Sasada T; Ghendler Y; Neveu JM; Lane WS; Reinherz EL
    J Exp Med; 2001 Oct; 194(7):883-92. PubMed ID: 11581311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Point mutations in the beta chain CDR3 can alter the T cell receptor recognition pattern on an MHC class I/peptide complex over a broad interface area.
    Goyarts EC; Vegh Z; Kalergis AM; Hörig H; Papadopoulos NJ; Young AC; Thomson CT; Chang HC; Joyce S; Nathenson SG
    Mol Immunol; 1998 Jul; 35(10):593-607. PubMed ID: 9823758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topology of T cell receptor-peptide/class I MHC interaction defined by charge reversal complementation and functional analysis.
    Chang HC; Smolyar A; Spoerl R; Witte T; Yao Y; Goyarts EC; Nathenson SG; Reinherz EL
    J Mol Biol; 1997 Aug; 271(2):278-93. PubMed ID: 9268659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparate peptide-dependent thymic selection outcomes in beta2M-deficient mice versus TAP-1-deficient mice: implications for repertoire formation.
    Sasada T; Yang Y; Lai CC; Touma M; Clayton LK; Liu JH; Parisini E; Wang JH; Reinherz EL
    Eur J Immunol; 2003 Feb; 33(2):368-80. PubMed ID: 12645934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunobiological analysis of TCR single-chain transgenic mice reveals new possibilities for interaction between CDR3alpha and an antigenic peptide bound to MHC class I.
    Zhang W; Honda S; Wang F; DiLorenzo TP; Kalergis AM; Ostrov DA; Nathenson SG
    J Immunol; 2001 Oct; 167(8):4396-404. PubMed ID: 11591764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major histocompatibility complex recognition by immune receptors: differences among T cell receptor versus antibody interactions with the VSV8/H-2Kb complex.
    Witte T; Smolyar A; Spoerl R; Goyarts EC; Nathenson SG; Reinherz EL; Chang HC
    Eur J Immunol; 1997 Jan; 27(1):227-33. PubMed ID: 9022023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-positive T cell receptor(high) thymocytes are resistant to peptide/major histocompatibility complex ligand-induced negative selection.
    Ghendler Y; Hussey RE; Witte T; Mizoguchi E; Clayton LK; Bhan AK; Koyasu S; Chang HC; Reinherz EL
    Eur J Immunol; 1997 Sep; 27(9):2279-89. PubMed ID: 9341770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in TCR-MHC contacts subsequent to cross-recognition of class I MHC and singly substituted peptide variants.
    Ono T; DiLorenzo TP; Wang F; Kalergis AM; Nathenson SG
    J Immunol; 1998 Nov; 161(10):5454-63. PubMed ID: 9820521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell receptor antagonist peptides induce positive selection.
    Hogquist KA; Jameson SC; Heath WR; Howard JL; Bevan MJ; Carbone FR
    Cell; 1994 Jan; 76(1):17-27. PubMed ID: 8287475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a common docking topology with substantial variation among different TCR-peptide-MHC complexes.
    Teng MK; Smolyar A; Tse AG; Liu JH; Liu J; Hussey RE; Nathenson SG; Chang HC; Reinherz EL; Wang JH
    Curr Biol; 1998 Mar; 8(7):409-12. PubMed ID: 9545202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hapten addition to an MHC class I-binding peptide causes substantial adjustments of the TCR structure of the responding CD8(+) T cells.
    Honda S; Zhang W; Kalergis AM; DiLorenzo TP; Wang F; Nathenson SG
    J Immunol; 2001 Oct; 167(8):4276-85. PubMed ID: 11591750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective absence of CD8+ TCRalpha beta+ intestinal epithelial cells in transgenic mice expressing beta2-microglobulin-associated ligands exclusively on thymic cortical epithelium.
    Capone M; Lees RK; Finke D; Ernst B; Meerwijk JP; MacDonald HR
    Eur J Immunol; 2003 Jun; 33(6):1471-7. PubMed ID: 12778464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical role for CD2 in both thymic selection events and mature T cell function.
    Sasada T; Reinherz EL
    J Immunol; 2001 Feb; 166(4):2394-403. PubMed ID: 11160298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive selection is limited by available peptide-dependent MHC conformations.
    Stefanski HE; Jameson SC; Hogquist KA
    J Immunol; 2000 Apr; 164(7):3519-26. PubMed ID: 10725706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A structural difference limited to one residue of the antigenic peptide can profoundly alter the biological outcome of the TCR-peptide/MHC class I interaction.
    Thomson CT; Kalergis AM; Sacchettini JC; Nathenson SG
    J Immunol; 2001 Mar; 166(6):3994-7. PubMed ID: 11238645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of peptides in T cell alloreactivity is determined by self-major histocompatibility complex molecules.
    Obst R; Netuschil N; Klopfer K; Stevanović S; Rammensee HG
    J Exp Med; 2000 Mar; 191(5):805-12. PubMed ID: 10704462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-positive selection of thymocytes expressing a single TCR by multiple major histocompatibility complex molecules of both classes: implications for CD4+ versus CD8+ lineage commitment.
    Eshima K; Suzuki H; Shinohara N
    J Immunol; 2006 Feb; 176(3):1628-36. PubMed ID: 16424192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The T-Cell Receptor Can Bind to the Peptide-Bound Major Histocompatibility Complex and Uncomplexed β
    Merkle PS; Irving M; Hongjian S; Ferber M; Jørgensen TJD; Scholten K; Luescher I; Coukos G; Zoete V; Cuendet MA; Michielin O; Rand KD
    Biochemistry; 2017 Aug; 56(30):3945-3961. PubMed ID: 28671821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.